LIPIDEM

This brand name is authorized in Brazil, Estonia, Hong Kong SAR China, Poland, UK.

Active ingredients

The drug LIPIDEM contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Triglycerides, medium chain UNII `C9H2L21V7U` - MEDIUM-CHAIN TRIGLYCERIDES
	Read more about Triglycerides, medium chain
`2`	Omega-3-acid ethyl esters UNII `71M78END5S` - OMEGA-3 FATTY ACIDS
	Read more about Omega-3-acid ethyl esters
`3`	Soybean oil, refined UNII `241ATL177A` - SOYBEAN OIL
	Read more about Soybean oil, refined

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	520906401158415, 520920080013207, 520920080013307
EE	Ravimiamet	1639638, 1639649, 1639650, 1639661, 1639672, 1639683, 1639694, 1639706
GB	Medicines & Healthcare Products Regulatory Agency	114691, 114701, 114705, 239859, 239861, 239863
HK	Department of Health Drug Office	58945
PL	Rejestru Produktów Leczniczych	100333299

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.